Evidence map›Paper›PMID 21878621›Full record

ArticleThe Journal of biological chemistry2011

Deletion of betaine-homocysteine S-methyltransferase in mice perturbs choline and 1-carbon metabolism, resulting in fatty liver and hepatocellular carcinomas.

Ya-Wen Teng, Mihai G Mehedint, Timothy A Garrow, Steven H Zeisel

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 125 papers.

0numbers the graph read from it
0cells of the map it votes in
125citing papers in PubMed
13.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

125 citing papers in PubMed, 215 citations in OpenAlex.

  1. Article
  2. Complementary hyperpolarizedNpj imaging · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

65 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Ya-Wen TengDepartment of Nutrition, School of Public Health, University of North Carolina, Chapel Hill, North Carolina 27599, USA.
Mihai G Mehedint
Timothy A Garrow
Steven H Zeisel
David H. Murdock Research Institute · USUniversity of Illinois Urbana-Champaign · USUniversity of North Carolina at Chapel Hill · US

Funding

UNC-CH CENTER FOR ENVIRONMENTAL HEALTH &SUSCEPTIBILITYP30ES010126 · NIEHS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Melissa A. Troester · 2001 to 2026
$36.3M
HUMAN REQUIREMENTS FOR THE NUTRIENT CHOLINER01DK055865 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI ZEISEL, STEVEN H · 2000 to 2011
$7.6M
Nutrient Regulation of BHMT ExpressionR01DK052501 · NIDDK · UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN · PI GARROW, TIMOTHY A · 2003 to 2006
$1.3M
NUTRIENT REGULATION OF BHMT EXPRESSIONR29DK052501 · NIDDK · UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN · PI GARROW, TIMOTHY A · 1997 to 2003
$310k
NIDDK NIH HHS DK36530NIDDK NIH HHS DK55865NIDDK NIH HHS R01 DK052501NIDDK NIH HHS R01 DK055865NIDDK NIH HHS R29 DK052501NIEHS NIH HHS P30 ES010126
6 · The paper itself

Abstract

Betaine-homocysteine S-methyltransferase (BHMT) uses betaine to catalyze the conversion of homocysteine (Hcy) to methionine. There are common genetic polymorphisms in the BHMT gene in humans that can alter its enzymatic activity. We generated the first Bhmt(-/-) mouse to model the functional effects of mutations that result in reduced BHMT activity. Deletion of Bhmt resulted in a 6-fold increase (p < 0.01) in hepatic and an 8-fold increase (p < 0.01) in plasma total Hcy concentrations. Deletion of Bhmt resulted in a 43% reduction in hepatic S-adenosylmethionine (AdoMet) (p < 0.01) and a 3-fold increase in hepatic S-adenosylhomocysteine (AdoHcy) (p < 0.01) concentrations, resulting in a 75% reduction in methylation potential (AdoMet:AdoHcy) (p < 0.01). Bhmt(-/-) mice accumulated betaine in most tissues, including a 21-fold increase in the liver concentration compared with wild type (WT) (p < 0.01). These mice had lower concentrations of choline, phosphocholine, glycerophosphocholine, phosphatidylcholine, and sphingomyelin in several tissues. At 5 weeks of age, Bhmt(-/-) mice had 36% lower total hepatic phospholipid concentrations and a 6-fold increase in hepatic triacyglycerol concentrations compared with WT (p < 0.01), which was due to a decrease in the secretion of very low density lipoproteins. At 1 year of age, 64% of Bhmt(-/-) mice had visible hepatic tumors. Histopathological analysis revealed that Bhmt(-/-) mice developed hepatocellular carcinoma or carcinoma precursors. These results indicate that BHMT has an important role in Hcy, choline, and one-carbon homeostasis. A lack of Bhmt also affects susceptibility to fatty liver and hepatocellular carcinoma. We suggest that functional polymorphisms in BHMT that significantly reduce activity may have similar effects in humans.

Indexed as

AnimalsBetaine-Homocysteine S-MethyltransferaseCarbonCarcinoma, HepatocellularCholineFatty LiverGene DeletionHumansLipoproteins, VLDLMiceMice, KnockoutNeoplasm ProteinsPhospholipidsS-AdenosylmethionineTriglyceridesBetaine-Homocysteine S-MethyltransferaseBhmt protein, mouseCarbonCholineLipoproteins, VLDLNeoplasm ProteinsPhospholipidsS-AdenosylmethionineTriglycerides

Identifiers

PMID21878621
PMCPMC3196139
OpenAlexW2002613261

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.